Neelam is CEO of MedCity, the life sciences cluster organisation for London, which plays a pivotal role in bridging industry, NHS and academia. Neelam’s extensive experience spans the private, public and not-for-profit sectors. She has worked with the Association of British Pharmaceutical Industries, the European Innovative Medicines Initiative and collaborated with NHS England, NICE and Public Health England.
Neelam regularly supports companies with R&D, advising on the UK regulatory and access landscape. Other roles include being on the advisory board of the Pan-London NIHR Research Design Service, the advisory board of the Innovation Centre in Digital Molecular Technologies at the University of Cambridge, and the board of the Health Research Authority.